Barings’s Core Laboratories CLB Stock Holding History

Barings’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-6,367	Closed	-$737K	–	692
2018 Q3	$737K	Hold	6,367	–	–	0.01%	541
2018 Q2	$804K	Hold	6,367	–	–	0.01%	548
2018 Q1	$689K	Hold	6,367	–	–	0.01%	611
2017 Q4	$698K	Hold	6,367	–	–	0.01%	623
2017 Q3	$628K	Hold	6,367	–	–	0.01%	586
2017 Q2	$645K	Sell	6,367 -1,800	-22%	-$194K	0.02%	568
2017 Q1	$943K	Sell	8,167 -1,000	-11%	-$116K	0.02%	539
2016 Q4	$1.1M	Buy	9,167 +1,000	+12%	+$111K	0.03%	436
2016 Q3	$917K	Hold	8,167	–	–	0.02%	463
2016 Q2	$1.01M	Buy	8,167 +900	+12%	+$109K	0.03%	482
2016 Q1	$817K	Hold	7,267	–	–	0.02%	545
2015 Q4	$790K	Hold	7,267	–	–	0.02%	544
2015 Q3	$725K	Hold	7,267	–	–	0.02%	543
2015 Q2	$829K	Hold	7,267	–	–	0.03%	572
2015 Q1	$759K	Hold	7,267	–	–	0.02%	588
2014 Q4	$875K	Hold	7,267	–	–	0.02%	505
2014 Q3	$1.06M	Hold	7,267	–	–	0.02%	449
2014 Q2	$1.21M	Hold	7,267	–	–	0.04%	446
2014 Q1	$1.44M	Buy	7,267 +2,200	+43%	+$415K	0.05%	366
2013 Q4	$968K	Sell	5,067 -5,093	-50%	-$948K	0.04%	428
2013 Q3	$1.72M	Buy	+10,160	New	+$1.58M	0.07%	305

Other funds holding CLB

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

EIP

Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

Barings's CLB Position: Q4 2018 in Review

Barings sold out of Core Laboratories (CLB) in Q4 2018, closing a stake of 6,367 shares — an estimated $737K sold.

Barings first reported a position in CLB in Q3 2013 and held it in 21 quarters. The position peaked at $1.72M in Q3 2013. 320 funds tracked by Wall St. Rank hold CLB as of Q4 2018.

Barings reported no remaining Core Laboratories position as of Q4 2018 after selling out during the quarter.
Barings sold 6,367 Core Laboratories shares in Q4 2018, an estimated $737K.
Barings first reported a position in Core Laboratories in Q3 2013 and held it in 21 quarters.
Barings's Core Laboratories position peaked at $1.72M in Q3 2013.
320 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2018.

Based on Barings's 13F filing for Q4 2018, filed 7 Feb 2019.